Allstate Corp Amgen Inc Transaction History

Allstate Corp

$1.2 Billion
Q2 2024

A detailed history of Allstate Corp transactions in Amgen Inc stock. As of the latest transaction made, Allstate Corp holds 1,774 shares of AMGN stock, worth $560,584. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,774

Previous 1,779 0.28%

Holding current value

$560,584

Previous $505,000 9.7%

% of portfolio

0.05%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $1,313 - $1,596	-5 Reduced 0.28%	1,774 $554,000
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $1,613 - $1,947	-6 Reduced 0.34%	1,779 $505,000
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $7,415 - $8,365	-29 Reduced 1.6%	1,785 $514,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $8,356 - $9,881	39 Added 2.2%	1,814 $402,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $5.33 Million - $6.49 Million	-23,585 Reduced 93.0%	1,775 $429,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $63,899 - $81,191	279 Added 1.11%	25,360 $6.66 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $51,625 - $58,224	-230 Reduced 0.91%	25,081 $5.65 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $1.79 Million - $1.99 Million	-7,760 Reduced 23.46%	25,311 $6.16 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $985,399 - $1.09 Million	-4,494 Reduced 11.96%	33,071 $8 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $5.12 Million - $5.86 Million	25,726 Added 217.3%	37,565 $8.45 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $283,168 - $331,765	-1,334 Reduced 10.13%	11,839 $2.52 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $277,025 - $307,340	-1,186 Reduced 8.26%	13,173 $3.21 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $253,643 - $295,579	1,143 Added 8.65%	14,359 $3.57 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $127,231 - $151,509	-588 Reduced 4.26%	13,216 $3.04 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $678,373 - $754,406	-2,891 Reduced 17.32%	13,804 $3.51 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $250,031 - $306,823	-1,264 Reduced 7.04%	16,695 $3.94 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $6.76 Million - $8.96 Million	-37,080 Reduced 67.37%	17,959 $3.64 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $112,958 - $145,190	597 Added 1.1%	55,039 $13.3 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2.36 Million - $2.82 Million	13,541 Added 33.11%	54,442 $10.5 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $5.82 Million - $6.82 Million	-34,925 Reduced 46.06%	40,901 $7.54 Million
Q1 2019 May 20, 2019	BUY	$180.87 - $203.88 $25,683 - $28,950	142 Added 0.19%	75,826 $14.4 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $13.3 Million - $15.6 Million	74,705 Added 7630.75%	75,684 $14.7 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $181,398 - $204,503	979 New	979 $203,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account